A detailed history of Great Diamond Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Great Diamond Partners, LLC holds 36,636 shares of NVO stock, worth $5.22 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
36,636
Previous 32,844 11.55%
Holding current value
$5.22 Million
Previous $3.4 Million 38.48%
% of portfolio
1.1%
Previous 0.85%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$102.11 - $135.92 $387,201 - $515,408
3,792 Added 11.55%
36,636 $4.7 Million
Q4 2023

Feb 07, 2024

SELL
$87.78 - $105.45 $64,254 - $77,189
-732 Reduced 2.18%
32,844 $3.4 Million
Q3 2023

Oct 19, 2023

BUY
$90.94 - $199.54 $1.54 Million - $3.37 Million
16,909 Added 101.45%
33,576 $3.05 Million
Q2 2023

Jul 17, 2023

BUY
$155.98 - $172.65 $1.08 Million - $1.19 Million
6,916 Added 70.93%
16,667 $2.7 Million
Q1 2023

May 04, 2023

SELL
$132.34 - $159.14 $100,843 - $121,264
-762 Reduced 7.25%
9,751 $1.55 Million
Q4 2022

Feb 01, 2023

BUY
$102.55 - $135.33 $40,199 - $53,049
392 Added 3.87%
10,513 $1.42 Million
Q3 2022

Oct 24, 2022

BUY
$95.28 - $116.93 $496,885 - $609,789
5,215 Added 106.3%
10,121 $1.01 Million
Q2 2022

Jul 26, 2022

BUY
$103.24 - $121.81 $31,901 - $37,639
309 Added 6.72%
4,906 $546,000
Q1 2022

May 05, 2022

BUY
$93.1 - $112.54 $166,835 - $201,671
1,792 Added 63.89%
4,597 $510,000
Q4 2021

Jan 26, 2022

BUY
$95.88 - $117.08 $10,450 - $12,761
109 Added 4.04%
2,805 $314,000
Q3 2021

Oct 21, 2021

BUY
$84.42 - $106.62 $24,566 - $31,026
291 Added 12.1%
2,696 $258,000
Q2 2021

Jul 26, 2021

BUY
$67.66 - $84.76 $162,722 - $203,847
2,405 New
2,405 $201,000
Q2 2020

Aug 04, 2020

SELL
$58.54 - $67.94 $364,704 - $423,266
-6,230 Closed
0 $0
Q1 2020

May 01, 2020

SELL
$49.46 - $64.78 $89,967 - $117,834
-1,819 Reduced 22.6%
6,230 $375,000
Q4 2019

Feb 07, 2020

BUY
$49.86 - $58.26 $401,323 - $468,934
8,049 New
8,049 $465,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $321B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Great Diamond Partners, LLC Portfolio

Follow Great Diamond Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Diamond Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Diamond Partners, LLC with notifications on news.